Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
859 INR | -0.21% | +0.06% | +32.30% |
23/05 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
22/05 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.30% | 95Cr | |
+15.37% | 4.2TCr | |
+22.56% | 2.23TCr | |
+14.89% | 1.52TCr | |
+16.53% | 1.4TCr | |
+49.78% | 1.21TCr | |
-10.77% | 679.6Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+14.18% | 549.33Cr |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug